An important aspect of the Comprehensive In Vitro Proarrhythmia Assay (CiPA) proposal is the use of human stem cell-derived cardiomyocytes and the confirmation of their predictive power in drug safety assays. The benefits of this cell source are clear; drugs can be tested in vitro on human cardiomyocytes. with patient-specific genotypes if needed. and differentiation efficiencies are ... https://www.chiggate.com/aptamil-allerpro-syneo-2-900g-online-now/